PDB Short entry for 1OWA
HEADER    CYTOKINE                                28-MAR-03   1OWA              
TITLE     SOLUTION STRUCTURAL STUDIES ON HUMAN ERYTHROCYTE ALPHA SPECTRIN N     
TITLE    2 TERMINAL TETRAMERIZATION DOMAIN                                      
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: SPECTRIN ALPHA CHAIN, ERYTHROCYTE;                         
COMPND   3 CHAIN: A;                                                            
COMPND   4 FRAGMENT: RESIDUES 1-156;                                            
COMPND   5 SYNONYM: ERYTHROID ALPHA-SPECTRIN;                                   
COMPND   6 ENGINEERED: YES                                                      
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;                                   
SOURCE   3 ORGANISM_COMMON: HUMAN;                                              
SOURCE   4 ORGANISM_TAXID: 9606;                                                
SOURCE   5 GENE: SPTA1;                                                         
SOURCE   6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;                                 
SOURCE   7 EXPRESSION_SYSTEM_TAXID: 562                                         
KEYWDS    TRIPLE HELICAL BUNDLE, CYTOKINE                                       
EXPDTA    SOLUTION NMR                                                          
NUMMDL    10                                                                    
AUTHOR    S.PARK,M.S.CAFFREY,M.E.JOHNSON,L.W.FUNG                               
REVDAT   3   23-FEB-22 1OWA    1       REMARK                                   
REVDAT   2   24-FEB-09 1OWA    1       VERSN                                    
REVDAT   1   30-MAR-04 1OWA    0                                                
JRNL        AUTH   S.PARK,M.S.CAFFREY,M.E.JOHNSON,L.W.FUNG                      
JRNL        TITL   SOLUTION STRUCTURAL STUDIES ON HUMAN ERYTHROCYTE             
JRNL        TITL 2 ALPHA-SPECTRIN TETRAMERIZATION SITE.                         
JRNL        REF    J.BIOL.CHEM.                  V. 278 21837 2003              
JRNL        REFN                   ISSN 0021-9258                               
JRNL        PMID   12672815                                                     
JRNL        DOI    10.1074/JBC.M300617200                                       
REMARK   2                                                                      
REMARK   2 RESOLUTION. NOT APPLICABLE.                                          
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : CNS 1.1, CNS 1.1                                     
REMARK   3   AUTHORS     : BRUNGER (CNS), BRUNGER (CNS)                         
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: NULL                                      
REMARK   4                                                                      
REMARK   4 1OWA COMPLIES WITH FORMAT V. 3.15, 01-DEC-08                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 03-APR-03.                  
REMARK 100 THE DEPOSITION ID IS D_1000018731.                                   
REMARK 210                                                                      
REMARK 210 EXPERIMENTAL DETAILS                                                 
REMARK 210  EXPERIMENT TYPE                : NMR                                
REMARK 210  TEMPERATURE           (KELVIN) : 293                                
REMARK 210  PH                             : 6.5                                
REMARK 210  IONIC STRENGTH                 : 5MM PHOSPHATE, 150MM NACL          
REMARK 210  PRESSURE                       : AMBIENT                            
REMARK 210  SAMPLE CONTENTS                : 1MM SPECTRIN, 5MM PHOSPHATE,       
REMARK 210                                   150MM NACL, 5% D2O, 95 % H2O       
REMARK 210                                                                      
REMARK 210  NMR EXPERIMENTS CONDUCTED      : 2D NOESY; 2D TOCSY; 3D_13C         
REMARK 210                                   -SEPARATED_NOESY; 3D_15N-          
REMARK 210                                   SEPARATED_NOESY; 4D_13C-           
REMARK 210                                   SEPARATED_NOESY                    
REMARK 210  SPECTROMETER FIELD STRENGTH    : 600 MHZ; 750 MHZ                   
REMARK 210  SPECTROMETER MODEL             : DRX; DMX                           
REMARK 210  SPECTROMETER MANUFACTURER      : BRUKER                             
REMARK 210                                                                      
REMARK 210  STRUCTURE DETERMINATION.                                            
REMARK 210   SOFTWARE USED                 : NULL                               
REMARK 210   METHOD USED                   : TORSION ANGLE DYNAMICS             
REMARK 210                                                                      
REMARK 210 CONFORMERS, NUMBER CALCULATED   : 200                                
REMARK 210 CONFORMERS, NUMBER SUBMITTED    : 10                                 
REMARK 210 CONFORMERS, SELECTION CRITERIA  : LOWEST ENERGY CONFORMERS           
REMARK 210                                                                      
REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1                   
REMARK 210                                                                      
REMARK 210 REMARK: NULL                                                         
REMARK 215                                                                      
REMARK 215 NMR STUDY                                                            
REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION           
REMARK 215 NMR DATA.  PROTEIN DATA BANK CONVENTIONS REQUIRE THAT                
REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON              
REMARK 215 THESE RECORDS ARE MEANINGLESS.                                       
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1                                                       
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC                         
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A                                     
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: CLOSE CONTACTS                                             
REMARK 500                                                                      
REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT.                            
REMARK 500                                                                      
REMARK 500  ATM1  RES C  SSEQI   ATM2  RES C  SSEQI           DISTANCE          
REMARK 500   HE1  TRP A    68     HB3  GLU A   100              1.24            
REMARK 500   O    THR A    20     H    ILE A    24              1.52            
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: TORSION ANGLES                                             
REMARK 500                                                                      
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:            
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                             
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)                    
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-           
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400            
REMARK 500                                                                      
REMARK 500  M RES CSSEQI        PSI       PHI                                   
REMARK 500  1 LEU A  49      101.01     56.64                                   
REMARK 500  1 GLU A  50     -102.75   -162.36                                   
REMARK 500  2 GLU A  50      -44.09     80.45                                   
REMARK 500  2 THR A  85      -73.12    -83.30                                   
REMARK 500  2 ILE A  87       89.20   -162.74                                   
REMARK 500  2 PHE A 119       65.67     60.40                                   
REMARK 500  3 LYS A  16      118.23     64.25                                   
REMARK 500  3 GLU A  50       95.19     87.57                                   
REMARK 500  4 ASP A  51      109.18     65.77                                   
REMARK 500  4 GLU A  82      -79.96    -89.93                                   
REMARK 500  4 PHE A 119      -90.14     39.46                                   
REMARK 500  4 THR A 120       20.88   -161.29                                   
REMARK 500  4 MET A 121      178.93     49.33                                   
REMARK 500  5 SER A  13      -26.93   -162.58                                   
REMARK 500  5 LYS A  16       60.27   -159.98                                   
REMARK 500  5 GLU A  50      106.21   -178.77                                   
REMARK 500  5 PRO A  84      156.21    -47.94                                   
REMARK 500  5 ARG A 118     -105.48   -106.48                                   
REMARK 500  5 THR A 120       27.89   -157.21                                   
REMARK 500  6 GLU A   2       79.54     62.82                                   
REMARK 500  6 LYS A   6      179.95     79.22                                   
REMARK 500  6 LEU A  49      -80.00    -90.02                                   
REMARK 500  6 PRO A  84       52.17    -68.45                                   
REMARK 500  6 PHE A 119       96.16     60.09                                   
REMARK 500  6 MET A 121      100.92     63.67                                   
REMARK 500  7 SER A  13        9.91   -157.81                                   
REMARK 500  7 LEU A  49      -64.67   -161.50                                   
REMARK 500  7 ASP A  51      102.29     69.42                                   
REMARK 500  7 THR A  85      -70.41    -79.91                                   
REMARK 500  7 ILE A  87       87.30   -154.81                                   
REMARK 500  8 GLU A   2     -175.44     59.29                                   
REMARK 500  8 GLU A  11      141.32     71.32                                   
REMARK 500  8 GLU A  82      -87.40   -126.03                                   
REMARK 500  8 PRO A  84     -175.56    -61.13                                   
REMARK 500  8 ILE A  87      -86.73     36.50                                   
REMARK 500  8 THR A 120       28.26   -157.00                                   
REMARK 500  8 MET A 121      -36.28   -152.11                                   
REMARK 500  9 LEU A  49      -43.46   -155.40                                   
REMARK 500  9 GLU A  50      106.39     79.50                                   
REMARK 500  9 PRO A  84     -166.14    -78.28                                   
REMARK 500  9 ILE A  87      -62.80     70.79                                   
REMARK 500  9 THR A 120     -171.96     43.28                                   
REMARK 500 10 GLU A  50       17.63     46.47                                   
REMARK 500 10 ASP A  51      -73.05    -90.32                                   
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
DBREF  1OWA A    1   156  UNP    P02549   SPTA1_HUMAN      1    156             
SEQRES   1 A  156  MET GLU GLN PHE PRO LYS GLU THR VAL VAL GLU SER SER          
SEQRES   2 A  156  GLY PRO LYS VAL LEU GLU THR ALA GLU GLU ILE GLN GLU          
SEQRES   3 A  156  ARG ARG GLN GLU VAL LEU THR ARG TYR GLN SER PHE LYS          
SEQRES   4 A  156  GLU ARG VAL ALA GLU ARG GLY GLN LYS LEU GLU ASP SER          
SEQRES   5 A  156  TYR HIS LEU GLN VAL PHE LYS ARG ASP ALA ASP ASP LEU          
SEQRES   6 A  156  GLY LYS TRP ILE MET GLU LYS VAL ASN ILE LEU THR ASP          
SEQRES   7 A  156  LYS SER TYR GLU ASP PRO THR ASN ILE GLN GLY LYS TYR          
SEQRES   8 A  156  GLN LYS HIS GLN SER LEU GLU ALA GLU VAL GLN THR LYS          
SEQRES   9 A  156  SER ARG LEU MET SER GLU LEU GLU LYS THR ARG GLU GLU          
SEQRES  10 A  156  ARG PHE THR MET GLY HIS SER ALA HIS GLU GLU THR LYS          
SEQRES  11 A  156  ALA HIS ILE GLU GLU LEU ARG HIS LEU TRP ASP LEU LEU          
SEQRES  12 A  156  LEU GLU LEU THR LEU GLU LYS GLY ASP GLN LEU LEU ARG          
HELIX    1   1 THR A   20  GLY A   46  1                                  27    
HELIX    2   2 SER A   52  GLU A   82  1                                  31    
HELIX    3   3 ASN A   86  ARG A  118  1                                  33    
HELIX    4   4 GLY A  122  LEU A  155  1                                  34    
CRYST1    1.000    1.000    1.000  90.00  90.00  90.00 P 1           1          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      1.000000  0.000000  0.000000        0.00000                         
SCALE2      0.000000  1.000000  0.000000        0.00000                         
SCALE3      0.000000  0.000000  1.000000        0.00000